《《IgA肾病治疗进展》.pdfVIP

BRIEF REVIEW Current Therapy for IgA Nephropathy Ju¨ rgen Floege and Frank Eitner Division of Nephrology and Immunology, RWTH University of Aachen, Aachen, Germany ABSTRACT IgA nephropathy (IgAN) is a very common glomerulonephritis worldwide. In this are detected in 5 to 20% of all cases. Full- review, we discuss therapeutic options in four clinical scenarios encountered in blown IgAN with glomerular IgA plus C3 patients with IgAN: first is the patient with minor urinary abnormalities where the deposits as